Incyte (INCY) Current Deferred Revenue (2010 - 2016)

Incyte has reported Current Deferred Revenue for 7 years, with the latest figure at $2.9 million in Q3 2016.

• For the quarter ending Q3 2016, Current Deferred Revenue fell 77.69% year-over-year to $2.9 million; the trailing twelve-month figure through Sep 2016 stood at $2.9 million (down 77.69% YoY), and the FY2015 full-year result was $12.5 million, down 2.86% from the prior year.
• Current Deferred Revenue for Q3 2016 stood at $2.9 million, down from $6.1 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $67.0 million in Q2 2012, with the low at $2.9 million in Q3 2016.
• Historically, Current Deferred Revenue has averaged $24.0 million across 5 years, with a median of $12.9 million in 2014.
• Annual changes were most pronounced in 2012 — Current Deferred Revenue slumped 91.03% — and 2013, when it jumped 775.17%.
• Incyte's Current Deferred Revenue stood at $66.1 million in 2012, then sank by 80.49% to $12.9 million in 2013, then decreased by 0.08% to $12.9 million in 2014, then dropped by 2.86% to $12.5 million in 2015, then slumped by 77.08% to $2.9 million in 2016.
• The last three Current Deferred Revenue figures came in at $2.9 million (Q3 2016), $6.1 million (Q2 2016), and $9.3 million (Q1 2016), per Business Quant data.